Viewing Study NCT01670994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-03-15 @ 10:46 AM
Study NCT ID: NCT01670994
Status: TERMINATED
Last Update Posted: 2024-06-18
First Post: 2012-08-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Altor BioScience
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None immunotherapy View
None immunochemotherapy View
None targeted View
None metastatic View
None interleukin-2 View
None antitumor View
None TCR View
None T-cell receptor View
None p53 View
None p53 gene View
None p53 tumor supressor protein View
None HLA-A2 positive View
None HLA-A*0201/p53 aa264-272 View
None HLA complex View
None multiple myeloma View
None IFN-γ and TNF-α View
None refractory View
None relapsed View